Coronavirus vaccine developer CanSino offers shares in China’s second-most expensive initial public offering | South China Morning Post

Coronavirus vaccine developer CanSino offers shares in China’s second-most expensive initial public offering | South China Morning Post

More reads:

• Coronavirus vaccine developer CanSino offers shares in China’s second-most expensive IPO (South China Morning Post)
• China’s Lynk obtains rights to develop RAS inhibitors with Japanese researchers (BioWorld)
• ‘We will share our vaccine with the world.’ Inside the Chinese biotech firm leading the fight against COVID-19 (Time)
• China-backed hackers 'targeted COVID-19 vaccine firm Moderna' (Reuters)